YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG: 1558)

Market Cap	7.67B
Revenue (ttm)	5.95B
Net Income (ttm)	1.77B
Shares Out	879.97M
EPS (ttm)	2.01
PE Ratio	4.34
Forward PE	3.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	902,800
Open	9.16
Previous Close	9.33
Day's Range	8.90 - 9.24
52-Week Range	6.14 - 13.30
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About YiChang HEC ChangJiang Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services. The company sells its products to hospitals and medical institutions through a network of...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 4,618
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1558

Financial Performance

In 2023, YiChang HEC ChangJiang Pharmaceutical's revenue was 6.29 billion, an increase of 68.08% compared to the previous year's 3.74 billion. Earnings were 1.99 billion, an increase of 2501.23%.

Financial numbers in CNY